Go Deep
Veracyte, Inc.
Veracyte, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,927 | 32.3 | 2.62 | 0.03 | 4,368.69 |
| Oct 2026 | 21,057 | 31.4 | 2.55 | 0.03 | 4,214.50 |
| Oct 2026 | 21,173 | 30.8 | 2.50 | 0.03 | 4,105.52 |
| Oct 2026 | 21,128 | 31.1 | 2.52 | 0.03 | 4,131.17 |
| Oct 2026 | 21,030 | 31.5 | 2.57 | 0.03 | 4,215.32 |
| Oct 2026 | 21,172 | 30.8 | 2.50 | 0.03 | 4,084.11 |
| Oct 2026 | 21,096 | 31.3 | 2.54 | 0.03 | 4,152.96 |
| Oct 2026 | 20,985 | 32.0 | 2.59 | 0.03 | 4,246.83 |
| Oct 2026 | 20,826 | 33.0 | 2.68 | 0.03 | 4,371.59 |
| Oct 2026 | 20,846 | 32.9 | 2.67 | 0.03 | 4,345.75 |
Veracyte, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 150,321,000.0 | 139,071,000.0 | 140,636,000.0 | 131,872,000.0 |
| Net Profit | 25,490,000.0 | 28,707,000.0 | 41,149,000.0 | 19,137,000.0 |
| EPS | 0.3 | 0.4 | 0.5 | 0.2 |
Veracyte, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 517,145,000.0 | 445,764,000.0 | 361,051,000.0 | 296,536,000.0 | — |
| Net Profit | 66,353,000.0 | 24,138,000.0 | -74,404,000.0 | -36,560,000.0 | — |
| EPS | 0.8 | 0.3 | -1.0 | -0.5 | — |
Veracyte, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 1,406,019,000.0 | 1,300,035,000.0 | 1,114,906,000.0 | 1,156,422,000.0 | — |
| Total Liabilities | 96,443,000.0 | 124,069,000.0 | 70,804,000.0 | 81,222,000.0 | — |
| Total Equity | 1,309,576,000.0 | 1,175,966,000.0 | 1,044,102,000.0 | 1,075,200,000.0 | — |
Owes vs Owns
Veracyte, Inc. owed $0.07 for every $1 it owned in Jun 2026, about the same as $0.07 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.07× | 0.07× | 0.10× | 0.06× | 0.07× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Veracyte, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 29.4%Receivables 3.2%Inventory 1.5%Fixed assets (tangible) 4.2%Intangible assets 60.9%Other assets 0.9%
How it's funded — Dec 2025
Long-term debt 2.5%Other liabilities 3.7%Shareholders' equity 93.1%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 412.9 | 289.4 | 216.5 | 178.9 |
| Receivables | 44.7 | 46.5 | 40.4 | 44.0 |
| Inventory | 20.5 | 21.8 | 16.1 | 14.3 |
| Fixed assets (tangible) | 58.8 | 71.1 | 30.9 | 30.9 |
| Intangible assets | 856.3 | 848.1 | 791.6 | 870.8 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 12.8 | 23.1 | 19.5 | 17.6 |
| Liabilities & equity | ||||
| Short-term debt | 4.1 | 7.5 | 5.1 | 4.1 |
| Long-term debt | 35.6 | 43.2 | 7.5 | 10.6 |
| Payables | 4.6 | 8.6 | 12.9 | 11.9 |
| Other liabilities | 52.2 | 64.7 | 45.2 | 54.6 |
| Shareholders' equity | 1,309.6 | 1,176.0 | 1,044.1 | 1,075.2 |
| Net tangible assets | 453.3 | 327.9 | 252.5 | 204.4 |
Veracyte, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 136,307,000.0 | 75,096,000.0 | 44,222,000.0 | 7,535,000.0 | — |
| Investing Activities | -9,209,000.0 | -56,275,000.0 | 15,112,000.0 | -29,387,000.0 | — |
| Financing Activities | -4,222,000.0 | 4,904,000.0 | 2,837,000.0 | 3,494,000.0 | — |